Guatemala’s National Health Laboratory is currently conducting genomic sequencing of SARS-CoV-2, the virus that causes COVID-19. This process aims to identify which specific variants of the virus are circulating within the country. Genomic sequencing allows health officials to understand the genetic makeup of the virus and track its evolution. The data collected will be crucial for monitoring the spread of different strains and assessing their potential impact on public health. This surveillance is essential for informing public health strategies, including vaccination campaigns and preventative measures. The results of the sequencing are expected to provide a clearer picture of the current COVID-19 situation in Guatemala. This ongoing monitoring effort is a key component of the nation’s response to the pandemic.